Carter Melody C, Uzzaman Ashraf, Scott Linda M, Metcalfe Dean D, Quezado Zenaide
Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 10 Center Dr. MSC 1881, Bldg 10 Room 11C-213, Bethesda, MD 20892, USA.
Anesth Analg. 2008 Aug;107(2):422-7. doi: 10.1213/ane.0b013e31817e6d7c.
Pediatric mastocytosis consists of a spectrum of clinical variants characterized by increased numbers of resident mast cells in various organ systems. Mast cells are instrumental in mediating anaphylaxis and patients with mastocytosis are at risk to develop provoked and unprovoked episodes of anaphylaxis.
We examined perianesthetic records of patients with pediatric mastocytosis who were anesthetized for diagnostic and surgical procedures from 1993 to 2006. In addition, we conducted a literature review of the anesthetic experience in pediatric mastocytosis.
Twenty-two patients with pediatric mastocytosis, with a median age of 3.2 yr (range, 6 mo-20 yr) at the time of the procedure, were anesthetized for 29 diagnostic and surgical procedures. All variants of the disease are represented in this series. Most patients had a history of flushing, pruritus, gastro-esophageal reflux diseases, and abdominal pain; one patient had a history of spontaneous anaphylaxis. Routine anesthetic techniques were used and, despite the complexity of the disease, the perioperative courses were uncomplicated and without serious adverse events.
We reviewed the main features of pediatric mastocytosis, its anesthetic and perioperative implications, and describe a practical approach to the anesthetic management of pediatric patients with the disease. Although many drugs used routinely in anesthesia reportedly caused mast cell degranulation, deviations from routine anesthesia techniques are not necessarily warranted. However, an understanding of the anesthetic implications of the disease and meticulous preparation to treat possible adverse events are advised.
小儿肥大细胞增多症由一系列临床变异组成,其特征是各个器官系统中驻留肥大细胞数量增加。肥大细胞在介导过敏反应中起重要作用,肥大细胞增多症患者有发生诱发和非诱发过敏反应发作的风险。
我们检查了1993年至2006年因诊断和外科手术接受麻醉的小儿肥大细胞增多症患者的围麻醉期记录。此外,我们对小儿肥大细胞增多症的麻醉经验进行了文献综述。
22例小儿肥大细胞增多症患者在手术时的中位年龄为3.2岁(范围6个月至20岁),接受了29项诊断和外科手术。该系列代表了该疾病的所有变异类型。大多数患者有潮红、瘙痒、胃食管反流病和腹痛病史;1例患者有自发过敏反应病史。采用了常规麻醉技术,尽管疾病复杂,但围手术期过程顺利,无严重不良事件。
我们回顾了小儿肥大细胞增多症的主要特征、其麻醉和围手术期影响,并描述了对患有该疾病的小儿患者进行麻醉管理的实用方法。尽管据报道麻醉中常规使用的许多药物会导致肥大细胞脱颗粒,但不一定需要偏离常规麻醉技术。然而,建议了解该疾病的麻醉影响并精心准备以治疗可能的不良事件。